Epigral Ltd Q4 FY2024 Concall Summary

Source transcript PDF: https://assets.stockscans.in/docs/owxf84wvpfg324uxbyhddze0.pdf

Key Takeaways


Margin Recovery & Sustainability

Kotecha: "we believe that 25% in the range would be something which is definitely sustainable."

Derivatives & Specialty Mix Shift

Patel: "next target we have kept it is 70-30. So, 70% will be derivatives and specialty and 30% will be in the Chlor-Alkali business."

Capacity Expansion & Ramp-Up Timelines

ProjectCapacity / ScopeCommissioningOptimum Utilisation
CPVC resin (additional)45,000 tonsCommissioned; ramp in progressQ4 FY25 (4–5 months to optimum)
Chlorotoluene value chain3 blocks, 10–15 products (phase 1)Block-by-block over next 3–4 months; all by end-Q2 FY25End-Q4 FY25 (~60% utilisation by Q4)
CPVC compound facilityNot quantified separatelyQ1 and Q2 FY25Part of integrated CPVC chain
New project (unannounced)~INR250 crores capexAnnouncement in a couple of monthsNot stated

Demand & Realisation Outlook

Patel: "we are expecting very high growth in next coming five years or coming decade for this particular product... at least the demand will pick up almost double from here in next five years."

Competitive Dynamics & Industry Context

Patel: "in terms of caustic, there will be pressure a little bit, but we believe that going forward, our alumina capacity in India is growing... the demand will match probably in a couple of years. So, the pressure will be there on the caustic side, but not for a long term, for a short term."

Balance Sheet & Capital Allocation

Jain: "the kind of debt that we have, it looks like that it has peaked out in this current year, maybe in the next six months. Thereafter, with the cash flows coming in, it will only be coming down."

Guidance & Commitments

CommitmentSpecificsTimeline
Volume growthAround 15% volume growthFY25
EBITDA marginAround 25% range, sustainableFY25
Derivatives revenue mix55–60% of revenueFY25
Derivatives revenue mix70% derivatives and specialty, 30% Chlor-AlkaliBy FY27
CPVC resin additional capacityReach optimum utilisationQ4 FY25
Chlorotoluene projectAll blocks commissioned; product movement startsEnd-Q2 FY25 for commissioning; Q4 FY25 for product movement
Chlorotoluene utilisationReach ~60% utilisationEnd-Q4 FY25
All products at optimumFull utilisation across all productsFY26
Debt reductionDebt to come down from peak; preferential holding-company debt repaid firstNext six months
New project announcement~INR250 crores capex deployed toward new projectsAnnouncement in a couple of months

Key Metrics

MetricQ4 FY24
Revenue₹525 cr, +11% QoQ and -7% YoY
EBITDA₹155 cr, +27% QoQ
EBITDA margin30%, vs 26% in Q3 FY24 and 28% in Q4 FY23
PAT₹77 cr, +55% QoQ
PAT margin15%, vs 10% in Q3 FY24
FY24 revenue₹1,929 cr, -12% YoY
FY24 EBITDA margin25%
FY24 PAT₹196 cr, margin of 10%
FY24 ROCE17% including CWIP, 21% excluding CWIP, 24% on annualized EBIT
Sales volume growth+9% YoY and +4% QoQ
FY24 volume growth+15%
Capacity utilization83%, vs 81% in Q3 FY24
Derivative and specialty revenue share52%, vs 44% in Q3 FY24 and 38% in Q4 FY23
Net debt₹960 cr as of 31st Mar 2024, +₹98 cr YoY
FY24 capex₹405 cr
ECU~29,000 in Q4, ~28,500 for full FY24
Epichlorohydrin utilization~60%, vs ~55% in Q3 FY24
Chlorine captive consumption65% of total production
CPVC resin price~₹1,30,000 per ton
Dividend₹5 per share (50% on face value of ₹10)